136 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Condition: Non-Medullary Thyroid Cancer
Intervention:
22 Recruiting Pioglitazone in Follicular or Follicular Variant of Papillary Thyroid Cancers
Conditions: Follicular Thyroid Carcinoma;   Follicular Variant of Papillary Thyroid Carcinoma
Intervention: Drug: Pioglitazone
23 Unknown  Influence of Thyroid Hormones on the Woundhealing Process
Conditions: Thyroid Neoplasms;   Thyroid Carcinoma
Intervention: Procedure: blood sampling
24 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
25 Not yet recruiting Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Other: Placebo;   Drug: Selumetinib;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis
26 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207
27 Recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) 60 mg;   Drug: Placebo tablet;   Drug: Placebo capsule
28 Unknown  Diagnosing Thyroid Cancer Using a Blood Test
Condition: Differentiated Thyroid Cancer
Intervention:
29 Recruiting Study of External Beam Radiotherapy to Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Radiation: External Beam Radiotherapy
30 Recruiting Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
Condition: Thyroid Cancer
Intervention: Other: follow up visit
31 Unknown  Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
Condition: Thyroid Carcinoma
Intervention: Procedure: thyroidectomy
32 Unknown  Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Conditions: Thyroid Carcinoma;   Metastatic Sites Lung Bone Nodal
Intervention: Other: SPECT scan
33 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash
34 Not yet recruiting Ceritinib (LDK378) in Mutation and Oncogene Directed Therapy in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Conditions: Metastatic Anaplastic/Undifferentiated Thyroid Cancer;   Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Intervention: Drug: Ceritinib
35 Recruiting Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
Condition: Thyroid Cancer
Interventions: Other: Interdisciplinary Team-Based Approach;   Other: Usual Care Control
36 Recruiting The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
Conditions: Thyroid Carcinoma;   Hypothyroidism
Interventions: Other: Black Coffee;   Other: Coffee with Milk;   Other: Black Tea;   Other: Water
37 Recruiting A Trial of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Everolimus;   Drug: Pasireotide;   Drug: Everolimus and Pasireotide
38 Unknown  BRAF V600E Mutations In Papillary Thyroid Carcinoma
Condition: Papillary Thyroid Carcinoma
Intervention: Genetic: BRAF V600E POSITIVITY
39 Recruiting Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Condition: Thyroid Carcinoma
Interventions: Drug: Continuous pazopanib (Arm A);   Drug: Intermittent pazopanib (Arm B)
40 Recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years